Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Neurology
•
Neuro-infectious disease
•
Neurohospitalist
•
Hospital Medicine
When do you consider repeating CSF studies in a patient with suspected viral encephalitis but overall initially unrevealing CSF?
Related Questions
When do you consider using a paramedian approach for a lumbar puncture?
How do you balance the risk of unnecessary treatment with acyclovir against the risk of delaying treatment in encephalitis cases where CSF pleocytosis is absent?
Under what circumstances do you recommend POCUS guidance for lumbar puncture?
What is your approach to managing antimicrobial therapy for intra-abdominal infections to avoid unnecessary double anaerobic coverage, in light of associated risks and guidelines?
How would you approach the upfront management of a patient with acute unilateral vision loss with strong clinical risk factors for both cardioembolic stroke and GCA if an expedited MRI is not possible due to the presence of an AICD?
What is your recommendation for timing of urgent chemotherapy in patients with staph aureus bacteremia or endocarditis who require prolonged durations?
Do you routinely check cefepime levels in patient's with suspected cefepime-induced neurotoxicity?
Do you ever favor cefazolin over ceftriaxone for bacteremia with susceptible E. coli?
What is your hemoglobin target for PRBC transfusion in cases of acute brain injury?
Does TpA or TNK cause acute post infusion severe headache with no intracranial bleed?
